Bioharvest Sciences Analysis
| CNVCFDelisted Stock | USD 5.13 0.07 1.35% |
Bioharvest Sciences is overvalued with Real Value of 4.56 and Hype Value of 5.13. The main objective of Bioharvest Sciences otc analysis is to determine its intrinsic value, which is an estimate of what Bioharvest Sciences is worth, separate from its market price. There are two main types of Bioharvest Sciences' stock analysis: fundamental analysis and technical analysis.
The Bioharvest Sciences otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Bioharvest Sciences' ongoing operational relationships across important fundamental and technical indicators.
Bioharvest |
Bioharvest OTC Stock Analysis Notes
About 35.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.01. Bioharvest Sciences had not issued any dividends in recent years. BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product and medical cannabis. Canna-V-Cell Sciences is traded on OTC Exchange in the United States.The quote for Bioharvest Sciences is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Bioharvest Sciences please contact the company at 604 622 1186 or go to https://www.bioharvest.com.Bioharvest Sciences Investment Alerts
| Bioharvest Sciences is not yet fully synchronised with the market data | |
| Bioharvest Sciences generated a negative expected return over the last 90 days | |
| Bioharvest Sciences has a very high chance of going through financial distress in the upcoming years | |
| Bioharvest Sciences has accumulated 3.97 M in total debt with debt to equity ratio (D/E) of 1.62, which is about average as compared to similar companies. Bioharvest Sciences has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Bioharvest Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Bioharvest Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioharvest Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioharvest to invest in growth at high rates of return. When we think about Bioharvest Sciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 2.1 M. Net Loss for the year was (9.83 M) with profit before overhead, payroll, taxes, and interest of 670 K. | |
| Bioharvest Sciences has accumulated about 1.21 M in cash with (6.79 M) of positive cash flow from operations. | |
| Roughly 35.0% of Bioharvest Sciences shares are held by company insiders |
Bioharvest Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 75.88 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioharvest Sciences's market, we take the total number of its shares issued and multiply it by Bioharvest Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Bioharvest Profitablity
Bioharvest Sciences' profitability indicators refer to fundamental financial ratios that showcase Bioharvest Sciences' ability to generate income relative to its revenue or operating costs. If, let's say, Bioharvest Sciences is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Bioharvest Sciences' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Bioharvest Sciences' profitability requires more research than a typical breakdown of Bioharvest Sciences' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (2.69) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.45) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.45. Bioharvest Sciences Outstanding Bonds
Bioharvest Sciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bioharvest Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bioharvest bonds can be classified according to their maturity, which is the date when Bioharvest Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Bioharvest Sciences Predictive Daily Indicators
Bioharvest Sciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bioharvest Sciences otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Bioharvest OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Bioharvest Sciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bioharvest shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Bioharvest Sciences. By using and applying Bioharvest OTC Stock analysis, traders can create a robust methodology for identifying Bioharvest entry and exit points for their positions.
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product and medical cannabis. Canna-V-Cell Sciences is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Bioharvest Sciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Bioharvest Sciences information on this page should be used as a complementary analysis to other Bioharvest Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Bioharvest OTC Stock
If you are still planning to invest in Bioharvest Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bioharvest Sciences' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |